Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry.
Zhou Y#, Zhang Y#, Li M#, Ming T#, Zhang C, Huang C, Li J, Li F, Li H, Zhao E, Shu F, Liu L, Pan X, Gao Y, Tian L, Song L*, Huang H*, Liao W*. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry. 2024 Oct 4;9(100):eado8758. doi: 10.1126/sciimmunol.ado8758.